menu search

cullinan oncology posts updated data for cln-081 in nsclc egfr exon 20 patients

cullinan Oncology Inc (NASDAQ: CGEM) reported updated data from its ongoing Phase 1/2a trial of CLN-...

December 16, 2021, 1:04 pm

cullinan oncology posts updated data for cln-081 in nsclc egfr exon 20 patients

cullinan Oncology Inc (NASDAQ: CGEM) reported updated data from its ongoing Phase 1/2a trial of CLN-...

December 16, 2021, 1:04 pm

cullinan oncology posts updated data for cln-081 in nsclc egfr exon 20 patients

cullinan Oncology Inc (NASDAQ: CGEM) reported updated data from its ongoing Phase 1/2a trial of CLN-...

December 16, 2021, 1:04 pm


Search within

Pages Search Results: